WiseGuyReports published new report, titled “Breakthrough Therapies”
This report highlights the challenges and opportunities of developing breakthrough therapies, it compares and contrasts difference fast track drug development approaches (logistics, criteria, and implications) and the potential risk and rewards of gaining BTD. It analyzes BTD in different therapy areas (cardiovascular, central nervous systems and neurology, rare diseases, oncology and other diseases), leading companies, approved and pipeline products, pricing market access and product revenues. It reviews BTD successes and failures and discusses the different business strategies that companies have adopted in order to maximize the competitive advantage of BTD. It summarizes the current regulatory framework and the potential application of BTD in other regions of the world, and the potential to combine BTD with early access to medicine schemes to improve patient access to medicine to treat rare diseases and address areas of high unmet clinical need.
Profiles of major players in the industry
ACADIA PHARMACEUTICALS INC.
ADAPTIMMUNE THERAPEUTICS PLC
ADURO BIOTECH INC.
AIMMUNE THERAPEUTICS INC.
ALEXION PHARMACEUTICALS INC.
ANATARA LIFESCIENCES LIMITED
ARIAD PHARMACEUTICALS INC.
BOEHRINGER INGELHEIM GMBH
CELLDEX THERAPEUTICS INC.
CLOVIS ONCOLOGY INC.
DAIICHI SANKYO COMPANY, LIMITED
EISAI CO. LTD.
ELI LILLY AND COMPANY
F. HOFFMANN-LA ROCHE LTD.
GILEAD SCIENCES INC.
JUNO THERAPEUTICS INC.
KITE PHARMA INC.
MERCK & CO. INC.
Preliminary Clinical Evidence
PROGENICS PHARMACEUTICALS INC.
REGENERON PHARMACEUTICALS INC.
RHYTHM PHARMACEUTICALS INC.
SYNDAX PHARMACEUTICALS INC.
SYNEURX INTERNATIONAL CORPORATION
TEVA PHARMACEUTICALS INC.
VERTEX PHARMACEUTICALS INC.
WELLSTAT THERAPEUTICS CORPORATION
- An overview of the global markets for breakthrough therapies, their dynamics, and investment opportunities
- Analyses of global market trends, with data from 2015, 2016, and projections of compound annual growth rates (CAGRs) through 2022
- The challenges and opportunities of developing breakthrough therapies
- A compare and contrast of different fast track drug development approaches (logistics, criteria and implications) and the potential risk and rewards of gaining break through designation
- Analysis of the regulatory environment
- Coverage of the market's dynamics, specifically growth drivers, restraints, and opportunities
Wise Guy Reports is part of the Wise Guy Research Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe.
Email US at: [email protected]
Reach US at: +1 339 368 6938 (US) +44 208 133 9349 (US)
For accessing accurate and deep understanding and to gain latest insights and key developments in the area of your interest, we also have a list of conferences in which you will be interested in, for more information, cordially check
For updating knowledge or for thoroughly understanding various terminologies, we also have vast list of seminars for your reference, for more information cordially check
P: +44 208 133 9349
M: +1 646 845 9349